Company Page
Most Recent Insiders Activity
| Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
|---|---|---|---|---|---|---|---|---|
| 2024-02-01 | Altimmune, Inc. | Roberts M Scot
(Chief Scientific Officer) |
M | Common Stock, par value $0.0001 | A | 13941 | $0.00 - $0.00 | $0 |
| 2024-02-01 | Altimmune, Inc. | Roberts M Scot
(Chief Scientific Officer) |
F | Common Stock, par value $0.0001 | D | 4131 | $9.32 - $9.88 | $39,508 |
| 2024-02-01 | Altimmune, Inc. | Harris Matthew Scott
(Chief Medical Officer) |
M | Common Stock, par value $0.0001 | A | 13941 | $0.00 - $0.00 | $0 |
| 2024-02-01 | Altimmune, Inc. | Harris Matthew Scott
(Chief Medical Officer) |
F | Common Stock, par value $0.0001 | D | 4133 | $9.32 - $9.88 | $39,527 |
| 2024-02-01 | Altimmune, Inc. | Garg Vipin K
(President and CEO) |
M | Common Stock, par value $0.0001 | A | 35495 | $0.00 - $0.00 | $0 |
| 2024-02-01 | Altimmune, Inc. | Garg Vipin K
(President and CEO) |
F | Common Stock, par value $0.0001 | D | 15689 | $9.32 - $9.88 | $150,316 |
| 2024-01-30 | Altimmune, Inc. | Roberts M Scot
(Chief Scientific Officer) |
M | Common Stock, par value $0.0001 | A | 9275 | $0.00 - $0.00 | $0 |
| 2024-01-30 | Altimmune, Inc. | Roberts M Scot
(Chief Scientific Officer) |
F | Common Stock, par value $0.0001 | D | 2709 | $9.80 - $9.80 | $26,548 |
| 2024-01-31 | Altimmune, Inc. | Roberts M Scot
(Chief Scientific Officer) |
A | Common Stock, par value $0.0001 | A | 5860 | $2.69 - $2.69 | $15,763 |
| 2024-01-31 | Altimmune, Inc. | Jordt Raymond M
(Chief Business Officer) |
A | Common Stock, par value $0.0001 | A | 5030 | $2.69 - $2.69 | $13,530 |
| 2024-01-30 | Altimmune, Inc. | Harris Matthew Scott
(Chief Medical Officer) |
M | Common Stock, par value $0.0001 | A | 9275 | $0.00 - $0.00 | $0 |
| 2024-01-30 | Altimmune, Inc. | Harris Matthew Scott
(Chief Medical Officer) |
F | Common Stock, par value $0.0001 | D | 2709 | $9.80 - $9.80 | $26,548 |
| 2024-01-31 | Altimmune, Inc. | Harris Matthew Scott
(Chief Medical Officer) |
A | Common Stock, par value $0.0001 | A | 3257 | $2.69 - $2.69 | $8,761 |
| 2024-01-30 | Altimmune, Inc. | Garg Vipin K
(President and CEO) |
M | Common Stock, par value $0.0001 | A | 26775 | $0.00 - $0.00 | $0 |
| 2024-01-30 | Altimmune, Inc. | Garg Vipin K
(President and CEO) |
F | Common Stock, par value $0.0001 | D | 11697 | $9.80 - $9.80 | $114,630 |
| 2024-01-31 | Altimmune, Inc. | Garg Vipin K
(President and CEO) |
A | Common Stock, par value $0.0001 | A | 7889 | $2.69 - $2.69 | $21,221 |
| 2024-01-30 | Altimmune, Inc. | Eisenstadt Richard I
(Chief Financial Officer) |
M | Common Stock, par value $0.0001 | A | 9275 | $0.00 - $0.00 | $0 |
| 2024-01-30 | Altimmune, Inc. | Eisenstadt Richard I
(Chief Financial Officer) |
F | Common Stock, par value $0.0001 | D | 2175 | $9.80 - $9.80 | $21,315 |
| 2024-01-31 | Altimmune, Inc. | Eisenstadt Richard I
(Chief Financial Officer) |
A | Common Stock, par value $0.0001 | A | 4621 | $2.69 - $2.69 | $12,430 |
| 2024-01-01 | Altimmune, Inc. | Jordt Raymond M
(Chief Business Officer) |
M | Common Stock, par value $0.0001 | A | 9375 | $0.00 - $0.00 | $0 |
| 2024-01-01 | Altimmune, Inc. | Jordt Raymond M
(Chief Business Officer) |
F | Common Stock, par value $0.0001 | D | 2503 | $11.25 - $11.25 | $28,158 |
| 2023-12-29 | Altimmune, Inc. | Eisenstadt Richard I
(Chief Financial Officer) |
M | Common Stock, par value $0.0001 | A | 12500 | $0.00 - $0.00 | $0 |
| 2023-12-29 | Altimmune, Inc. | Eisenstadt Richard I
(Chief Financial Officer) |
F | Common Stock, par value $0.0001 | D | 3044 | $11.25 - $11.25 | $34,245 |
Activity types
| A | Grant, award or other acquisition |
| C | Conversion of Derivative or Security |
| D | Disposition to the issuer of issuer equity securities |
| E | Expiration of short derivative position |
| F | Payment of exercise price or tax liability |
| G | Bona fide Gift |
| H | Expiration (or cancellation) of long derivative position with value received |
| I | Discretionary Transaction |
| J | Other acquisition or disposition |
| K | Transaction in equity swap or instrument with similar characteristics |
| L | Small Acquisition |
| M | Exercise or conversion of derivative security |
| O | Exercise of out-of-the-money derivative security |
| P | Open Market Purchase |
| S | Open Market Sale |
| U | Disposition pursuant to a tender of shares in a change of control transaction |
| V | Transaction Voluntarily Reported |
| X | Exercise of in-the-money or at-the-money derivative security |
| Z | Deposit into or withdrawal from voting trust |